Skip to main content
. Author manuscript; available in PMC: 2015 Nov 25.
Published in final edited form as: Leukemia. 2015 May 28;29(11):2202–2207. doi: 10.1038/leu.2015.132

Table 1. Summary of ‘driver’ CNAs present at diagnosis versus relapse detected by SNP analysis.

chr start end cytoband CNA Loss/Gain Diagnosis Relapse Genes (max 3 listed)
1 chr6 78095353 93349377 6q14.1 - 6q16.1 Loss present absent IRAK1BP1, PHIP, SYNCRIP
2 chr7 50389071 50477011 7p12.2 Loss present absent IKZF1
3 chr9 16523946 21901150 9p22.3 - 9p21.3 Loss present absent MLLT3, MTAP, FOCAD
4 chr9 21901150 22347406 9p21.3 Homozygous Loss present absent CDKN2A, CDKN2B
5 chr9 36412035 38493465 9p13.2 - 9p13.1 Loss present absent MELK, PAX5, FRMPD1
6 chr12 68970862 69406845 12q15 Gain present absent RAP1B, NUP107, MDM2
7 chr 7 50389060 50486601 7p12.2 Loss absent present IKZF1
8 chr8 31254 43078119 8p23.3 - 8p11.21 Loss absent present ZNF596, FBXO25, DLGAP2
9 chr9 6988784 21926959 9p24.1 - 9p21.3 Loss absent present MPDZ, MLLT3, MTAP
10 chr9 21926959 22200408 9p21.3 Heterozygous Loss absent present CDKN2A, CDKN2B
11 chr9 22200408 132070825 9p21.3 – 9q34.11 Loss absent present MOB3B, LINGO2, PAX5
12 chr20 61305 62956154 20p13-20q13.33 Gain absent present DEFB125, DEFB126, TOP1
13 chr21 15939316 48096958 21q11.2 - 21q22.3 Loss absent present CHODL,CXADR,NCAM2

Based on NCBI37/hg19 Assembly